On June 3, 2024, Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited subsidiary, inaugurated a 70,000 sq. ft. biologics facility in Genome Valley, Hyderabad, India. The facility will support customers with the process, analytical development, and small-scale manufacturing of antibodies and other recombinant proteins for preclinical and early-phase clinical trials. While the process …